Markets
Ajanta Pharma Q1 Results FY26: Q1 PAT Rose 3.89% to ₹255.34 Crore; Revenue Surged 13.78% YoY
July 28, 2025
Posted by:
sachet
Categories:
Market, News
No Comments
read more
